AG
CTSO icon

Advisor Group’s Cytosorbents Corp CTSO Stock Holding History

Advisor Group’s Portfolio CTSO Stock Details CTSO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		$122K Sell
31,670
-1,200
-4% -$5.24K ﹤0.01% 2783
2019
Q3 		$165K Sell
32,870
-300
-0.9% -$1.75K ﹤0.01% 2461
2019
Q2 		$219K Buy
33,170
+4,530
+16% +$31.1K ﹤0.01% 2231
2019
Q1 		$217K Buy
28,640
+1,479
+5% +$11.5K ﹤0.01% 2216
2018
Q4 		$219K Buy
27,161
+3,160
+13% +$31.4K ﹤0.01% 2022
2018
Q3 		$310K Buy
24,001
+2,351
+11% +$29.5K ﹤0.01% 1836
2018
Q2 		$247K Sell
21,650
-1,898
-8% -$18K ﹤0.01% 1818
2018
Q1 		$166K Buy
23,548
+4,848
+26% +$36.6K ﹤0.01% 2124
2017
Q4 		$122K Buy
18,700
+2,000
+12% +$12.7K ﹤0.01% 2417
2017
Q3 		$104K Sell
16,700
-37,685
-69% -$192K ﹤0.01% 2364
2017
Q2 		$234K Sell
54,385
-276,810
-84% -$1.21M ﹤0.01% 1667
2017
Q1 		$1.49M Sell
331,195
-6,200
-2% -$34.6K 0.03% 548
2016
Q4 		$1.84M Buy
337,395
+31,250
+10% +$171K 0.04% 452
2016
Q3 		$1.96M Buy
306,145
+4,300
+1% +$22.3K 0.05% 409
2016
Q2 		$1.37M Buy
+301,845
New +$1.31M 0.04% 493

Other funds holding CTSO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SC
Skylands Capital Milwaukee, Wisconsin $814M AUM 32.37% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
SIG
Sargent Investment Group Bethesda, Maryland $759M AUM 28.58% 1-Year Est. Return
AC
Avenir Corporation Alexandria, Virginia $820M AUM 2.4% 1-Year Est. Return

Advisor Group's CTSO Position: Q4 2019 in Review

Advisor Group reduced its Cytosorbents Corp (CTSO) stake by 3.7% in Q4 2019, selling an estimated $5.24K and leaving 31,670 shares worth $122K. The position accounts for ﹤0.01% of the portfolio, ranked #2783.

Advisor Group first reported a position in CTSO in Q2 2016 and has held it in 15 quarters since. The position peaked at $1.96M in Q3 2016. 72 funds tracked by Wall St. Rank hold CTSO as of Q4 2019.

  • Advisor Group held 31,670 shares of Cytosorbents Corp worth $122K as of Q4 2019.
  • Advisor Group sold 1,200 Cytosorbents Corp shares in Q4 2019, an estimated $5.24K.
  • Cytosorbents Corp made up ﹤0.01% of Advisor Group's portfolio in Q4 2019, its #2783 holding.
  • Advisor Group first reported a position in Cytosorbents Corp in Q2 2016 and has held it in 15 quarters since.
  • Advisor Group's Cytosorbents Corp position peaked at $1.96M in Q3 2016.
  • 72 funds tracked by Wall St. Rank held Cytosorbents Corp as of Q4 2019.

Based on Advisor Group's 13F filing for Q4 2019, filed 12 Feb 2020.